Methods and compositions for production of human recombinant placental ribonuclease inhibitor
US5552302A · kind A · utility
15Cited by
7References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 1994 |
| Grant date | Sep 3, 1996 |
| Priority date | — |
| Expiry date | Jul 27, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The in vitro cloning of a gene for human placental ribonuclease inhibitor may be obtained by recombinant DNA technology. The method described obtains the gene encoding human placental ribonuclease inhibitor, the expression of that product in a host cell, and the refolding and purifying of the product. A vector which includes an encoded DNA gene sequence coding for human placental ribonuclease inhibitor is also described, as well as a host that is compatible with and contains the vector. The gene sequence of the human placental ribonuclease inhibitor is also presented.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.